Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II - Top-Institutions - MDSpire

Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II

  • By

  • Seema Parte

  • Ranjith Kumavath

  • Ramesh Pothuraju

  • Saurabh Sharma

  • Rakesh Bhatia

  • March 18, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Gastrointestinal Oncology
    • Cancer Metabolism
    • Tumor Microenvironment Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Gastrointestinal Oncology
    • Cancer Biology
    • Translational Cancer Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Gastrointestinal Oncology
    • Cancer Metabolism
    • Immuno-oncology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Gastrointestinal Oncology
    • Cancer Biomarkers
    • Translational Research

  • #5

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Cancer Metabolism
    • Gastrointestinal Oncology
    • Molecular Oncology

Original Source(s)

Editorial: Altered metabolic traits in gastro-intestinal tract cancers, volume II

  • by Seema Parte, Ranjith Kumavath, Ramesh Pothuraju, Saurabh Sharma, Rakesh Bhatia

  • March 18, 2026

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.